Citadel Advisors
HLTH

Citadel Advisors’s Cue Health Inc. Common Stock HLTH Stock Holding History

Citadel Advisors’s Portfolio HLTH Stock Details HLTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-10,200
Closed -$1.66K – 15688
2023
Q4 		$1.66K Buy
10,200
+9,800
+2,450% +$3.25K ﹤0.01% 13793
2023
Q3 		$177 Buy
400
+100
+33% +$46 ﹤0.01% 14142
2023
Q2 		$111 Sell
300
-41,600
-99% -$35.5K ﹤0.01% 14219
2023
Q1 		$76.3K Sell
41,900
-26,400
-39% -$57.4K ﹤0.01% 11626
2022
Q4 		$141K Buy
68,300
+21,600
+46% +$68.2K ﹤0.01% 10698
2022
Q3 		$141K Sell
46,700
-44,200
-49% -$157K ﹤0.01% 10781
2022
Q2 		$291K Sell
90,900
-59,200
-39% -$321K ﹤0.01% 9881
2022
Q1 		$968K Buy
150,100
+47,900
+47% +$433K ﹤0.01% 7770
2021
Q4 		$1.37M Buy
+102,200
New +$1.12M ﹤0.01% 7105

Other funds holding HLTH

TC
Tarsadia Capital New York $5.64M AUM 15.7% 1-Year Est. Return
OC
Oakmont Corp Los Angeles, California $526M AUM 7.52% 1-Year Est. Return
DC
Decheng Capital Menlo Park, California $661M AUM 299.97% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
JPC
Jabodon PT Co Reno, Nevada $1.02B AUM 22.14% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Citadel Advisors's HLTH Position: Q4 2023 in Review

Citadel Advisors sold out of Cue Health Inc. Common Stock (HLTH) in Q4 2023, closing a stake of 4,472 shares — an estimated $1.48K sold.

Citadel Advisors first reported a position in HLTH in Q3 2021 and held it in 3 quarters. The position peaked at $938K in Q3 2021. 63 funds tracked by Wall St. Rank hold HLTH as of Q4 2023.

  • Citadel Advisors reported no remaining Cue Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Citadel Advisors sold 4,472 Cue Health Inc. Common Stock shares in Q4 2023, an estimated $1.48K.
  • Citadel Advisors first reported a position in Cue Health Inc. Common Stock in Q3 2021 and held it in 3 quarters.
  • Citadel Advisors's Cue Health Inc. Common Stock position peaked at $938K in Q3 2021.
  • 63 funds tracked by Wall St. Rank held Cue Health Inc. Common Stock as of Q4 2023.

Based on Citadel Advisors's 13F filing for Q4 2023, filed 14 Feb 2024.